Investrix presents Nike (NKE) as the world's largest athletic outfitter. Forty-six billion in annual revenues, one hundred and ninety brand jurisdictions, and a stock near a four-year low. With wholesale channel growth of seven and eight percent in consecutive quarters and a thirty-two-year veteran as the new chief executive, he sees a self-inflicted wound in active repair. At a normalised earnings recovery toward four dollars per share, the current price implies thirteen times earnings for the world's dominant athletic brand.

Numerius has concerns. Gross margin has fallen from forty-six to forty point six percent over four years, with return on invested capital collapsing from thirty-four point nine to twenty point two in a single year. China revenues declined seventeen percent last quarter. And the stock trades at a sixty-one percent premium to its earnings power value of thirty-two dollars and sixty-five cents.

In the winter orchard, beside a branch he twice considers cutting and twice does not, Numerius offers a watchlist, not a verdict: wait for gross margin above forty-three point five percent and China to stop falling. Investrix sees thirteen times normalised earnings as a bargain. Numerius sees sixty-one percent of hope.

Who's right? And when, exactly, does "Win Now" begin?

Topics: NKE stock analysis, Nike valuation, gross margin recovery, Jordan brand durability, China revenue decline, tariff risk, athletic footwear competition